Grünenthal Gmbh

This study tested whether an experimental drug called RTX-GRT7039, given as a shot into the knee joint, can reduce pain in people with knee osteoarthritis. 469 adults who still had pain despite standard treatments took part. The main goal was to measure pain changes over 12 weeks…

This study tested an experimental injection called RTX-GRT7039 in 714 adults with moderate to severe knee osteoarthritis pain that wasn't helped by standard treatments. The goal was to see if the injection is safe and tolerable. Researchers measured side effects and changes in pa…

This study tested a single injection of RTX-GRT7039 in 466 adults with knee osteoarthritis pain that wasn't helped by standard treatments. The goal was to see if it reduces pain better than a placebo injection. Researchers measured pain changes at 12 and 26 weeks using a standard…

This early-stage trial tested a single dose of a new drug called GRT6019 in 18 healthy men to see if it is safe and how the body processes it. The study also looked at whether food changes how the drug works. No treatment was given for Duchenne muscular dystrophy (DMD); the resul…